| 000 | 01664 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517000705.0 | ||
| 264 | 0 | _c20150617 | |
| 008 | 201506s 0 0 eng d | ||
| 022 | _a1665-2681 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSilva, Mauricio F | |
| 245 | 0 | 0 |
_am-RECIST at 1 month and Child A are survival predictors after percutaneous ethanol injection of hepatocellular carcinoma. _h[electronic resource] |
| 260 |
_bAnnals of hepatology _c |
||
| 300 |
_a796-802 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xclassification |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aEthanol _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intralesional |
| 650 | 0 | 4 |
_aLiver Diseases _xclassification |
| 650 | 0 | 4 |
_aLiver Neoplasms _xclassification |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms, Multiple Primary _xdrug therapy |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aSolvents _xtherapeutic use |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aTumor Burden |
| 700 | 1 | _aCarrilho, Flair J | |
| 700 | 1 | _aParanaguá-Vezozzo, Denise C | |
| 700 | 1 | _aCampos, Luciana T | |
| 700 | 1 | _aNacif, Lucas S | |
| 700 | 1 | _aDiniz, Marcio A | |
| 700 | 1 | _aFarias, Alberto Q | |
| 700 | 1 | _aAlves, Venancio A F | |
| 700 | 1 | _aD'Alburquerque, Luis A C | |
| 700 | 1 | _aOno, Suzane K | |
| 773 | 0 |
_tAnnals of hepatology _gvol. 13 _gno. 6 _gp. 796-802 |
|
| 999 |
_c24294610 _d24294610 |
||